The holiday season is filled with get-togethers with family and friends and can be both fun and joyous. It can also be stressful and tiring at times. Experts warn about this combination of stress, fatigue, and high-fat foods—factors that can, over time, increase your risk of cancer. That’s why the…...
Male Smokers More Likely to Lose Y Chromosomes
By Gunjan Sinha If cancer, heart disease, and emphysema weren’t bad enough, male smokers may have another thing to worry about: losing their Y chromosomes. Researchers have found that smokers are up to four times more likely to have blood cells with no Y chromosome than nonsmokers. That’s worrisome, they…...
Signal Protein May Control Prostate Cancer Growth
Researchers are focusing on effects the signal protein has on controlling the growth of blood vessels could be used to suppress tumors in prostate cancer. Vascular endothelial growth factor (VEGF) inhibits vascular growth which is then able to deprive the tumor of its necessities to enlarge. If successful the new drug could be used as a long-term…...
Parthenogenetic Snakes May Cure Cancer
Recently, a professor at Tulsa College in Oklahoma made a breakthrough linking parthenogenetic snakes to curing ovarian cancer. Each year, over 14,000 women die of ovarian cancer, which also makes it one of the leading cancers in the US. Though the link between parthenogenetic snakes and ovarian cancer isn't certain,…...
3 Breakthroughs in Fight Against Breast Cancer
Recently, three breakthroughs have aided in the fight against breast cancer; three being chemoprevention, detection of circulation tumor cells and scintimammography. The main technology used in chemoprevention is Fenretinide, synthetic retinoid derivative, that is believed to reduce the chances of developing breast cancer. Scintimammography uses slightly radioactive tracer to further investigate…...
Stem Cell Treatments: New Breakthroughs in Leukemia, Liver Cancer, and Diabetes
Styem cell treatments have been a hot topic lately, and researchers have found a number of conditions that could benefit from this technique. An investigational personalized cellular therapy put 90 percent of children and adults with acute lymphoblastic leukemia (ALL) into remission, many of these individuals had suffered several relapses…...
